Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Northwest Biotherapeutics is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.

PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers; PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers. PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.

Xencor provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large cell lymphoma; XmAb5574, a humanized monoclonal antibody that targets the antigen CD19 for the treatment of B cell malignancies; XmAb5592 for the treatment of myeloma; and XmAb5871 and XmAb7195, which are humanized monoclonal antibodies for the treatment of asthma and allergy. The company’s products also include XPro protein therapeutics, such as XPro1595, a dominant-negative inhibitor for the treatment of multiple animal models of autoimmune and neuroinflammatory diseases.

Chengdu Maxhealth Biotechnology LLC is a Chinese company located in Chengdu that functions as a venture capital firm. It was founded in 2016 by de Xiang Xian Sheng Chen, who has been the CEO since the company founding.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom.

Josho Gakuen Educational Foundation provides academic courses and degrees through colleges, universities, and professional schools.

Beijing Fuyuan Technology Co., Ltd., established on 2019-02-22, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;Conference Services;Basic software service;Application software service(Does not contain medical software);Undertake exhibition and display activities;Organize cultural and artistic exchange activities(without show);Economic and Trade Consulting;Educational Consulting;design,make,acting,Place an ad;computer graphic design;software development;buisness planning;market survey;selling computers,Software and Auxiliary Equipment,communication equipment,Equipment,electronic product,Chemical Products(Free of Hazardous Chemicals),clothing,knitted goods,Ι class medical device,Instrumentation,Wujinjiaodian(E-bike not included),cosmetic;computer animation design.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD.

Hehong Shangyi (Chengdu) Biotechnology Co., Ltd., established on 2020-06-12, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Engineering and Technology Research and Experimental Development;Health Consulting Services(Does not include medical services);Health Care Services(non-medical);Technology intermediary service;Business Management Consulting;Cosmetics Retail;Sales of Class I Medical Devices;Wholesale of protective equipment for medical staff;Disinfectant sales(Free of Hazardous Chemicals);Human stem cell technology development and application;Cosmetics Wholesale;Sales of Class II Medical Devices;Healthy food(prepackaged)Sales;Medical Mask Retail;Specialty Chemicals Sales(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Drug Wholesale;food sales;medical service;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Vandrich (Shanghai) Biotechnology Co., Ltd., established on 2020-04-02, Business scope includes general items:engaged in biotechnology,Medical Technology,Technology development in the field of medical diagnosis and treatment technology,technical consulting,Technical Services,technology transfer(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Development of a class of medical devices,Sales,Cosmetic research and development,Sales,Biotechnology Extension Services(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval),business management,Business Management Consulting,Medical enterprise management service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)